Free Newsletters | Help  

  Current | By Company | NEW Products
Login ID:    Password:    Register for a FREE account
 NEWS

Industry News
Business
Organic
Food & Beverage
Sports Nutrition
Nutraceuticals
Regulatory
Research
Products
Practitioners
Retail
Events
People
On-line


 LISTINGS
  Categories
Products

Profiles
Publishers

 OPINION
  Editorials
Interviews
Up and Comers
Quality Initiatives

 
Blogs
Andrew Stewart  
Marc Ullman FYI Blog
Len Monheit Off The Cuff
James S. Tonkin - Formulating Beverages  
Jim Lassiter -- Good News/Bad News
The Nutrition Business Journal Blog

Join the NPIcenter LinkedIn Group Group
Join the Facebook page Page
Follow us on
Join the Facebook page


 FEATURES
 

Newsletter

  News Feeds
 
 SERVICES
  Log in
Register User
Add Company
Career Center
Advertise

 INFO CENTER
  Help
Contact Us
About NPI
Privacy Policy



 

Advertisement



Share Subscribe to NPIcenter Newsfeed

New Research Formula for Diabetics with Cardiovascular Complications
2009-07-08 - Exotic Naturals




Exotic Naturals announces the launch of E-DM-13, a Support formula for Diabetics. An innovative research formula, which is not only clinically proven to lower blood sugar levels but also controls serum nitrotyrosin, a key indicator for atherosclerotic disease.

“High blood glucose levels are one of the most common killers of Americans, according to new research from Harvard researchers.” (Nutraingredients.com) “About 60% of people with type II diabetes die of atherosclerotic cardiovascular disease.” (National Diabetes Advisory Board, 1987) Most of them are premature deaths when the people concerned are economically contributing to society. This situation is increasingly outstretching the health-care resources devoted to diabetes. (WHO, Fact Sheet N° 236, Revised September 2002). “Increased nitrotyrosine has been found in the plasma of diabetic patients and has been shown to be involved in the pathogenesis of atherosclerosis” (Ceriello A et al).

Exotic Naturals, CEO, Jayesh Chaudhary stated, “As the number of people with diabetes grows up to 230 millions worldwide, treatment of its long term complications take an ever-increasing proportion of national health care budgets. As per Exotic Naturals’ vision to improve human life, the utmost need is created for a natural product which can support diabetics with cardiovascular complications."

Exotic Naturals’ focus was to develop the herbal supplement with clinically proven efficacy & safety. Hence, this research-based firm took up development of E-DM-13, an effective solution to this worldwide phenomenon. In a clinical study of 126 patients with type 2 diabetes investigators were amazed to find that E-DM-13 could dramatically decrease (p<0.001) serum nitrotyrosine levels by a huge 90% compared to before treatment. E-DM-13 produced significant (p<0.05) improvements in levels of glycosylated hemoglobin (HbA1c), a standard indicator for glycemic control. Also fasting and post prandial plasma glucose levels showed a significant decrease compared to baseline (p<0.05). Unlike the inadequate safety profile of conventional drugs, E-DM-13 was found to be free from major side effects. No severe adverse events were noted during the study period. E-DM-13 also clears mutagenecity and genotoxicity tests and has undergone animal research over the last 4 years of development.

Company profile

Exotic Naturals is an innovation driven company which is focused on design and development of dietary ingredients and formulas with substantiated label claims. In keeping with its mission, Exotic has developed products in some of the fastest growing health categories - Male Sexual Dysfunction, Lipid Lowering and Diabetes Type 2, Allergies, Insomnia, Osteoarthritis & Antioxidants and lots more at the R&D stage. Exotic Naturals is offering these opportunities to alliance partners for co-development and co-marketing worldwide.

For more information on Exotic Naturals & its products visit www.exoticnatural.com or contact Rekha Patel (bizdev@exoticnatural.com)

Related Articles :

  • Exotic Naturals Ramps Up Clinical Efforts (2007-04-10)
    Company commits to start clinical development for at least 2 of their supplement formulas and ingredients that have already successfully completed preclinical work.
  • Exotic Naturals Introduces Spycus-D (2008-04-28)
    Exotic Naturals, in its endeavor to make living with diabetes easier, has developed a basket of products including newly introduced Spycus-D.
  • Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health (2009-01-06)
    Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
  •  

    Advertisement



    Sponsored Links: Featured Links:
     

    NPIcenter Address and Phone Number
    Contact Us | Privacy Policy | Terms of Use | Advertise
    New Hope Natural Media

     

    SUPPLYEXPO Funtional Foods & Nutraceuticals Magazine Healthy Foods Conferences The Newport Summit - Executive Retreat Nutracon